Paul Hrvatin

Title: Paul Hrvatin: Innovator in Protein Kinase Inhibitors

Introduction

Paul Hrvatin is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic potential. With a total of 2 patents, Hrvatin's work focuses on innovative solutions for treating various diseases.

Latest Patents

Hrvatin's latest patents include groundbreaking inventions such as dihydropyridine derivatives that serve as protein kinase inhibitors. This invention provides novel dihydropyridine derivatives of the formula I, which exhibit protein tyrosine kinase inhibitory activity. These compounds are designed for the treatment of c-Met-mediated diseases or conditions. Another significant patent involves indolinone derivatives, which are utilized in treating disease-states such as cancer. The compounds of this formula (I) represent a promising avenue for therapeutic intervention.

Career Highlights

Throughout his career, Paul Hrvatin has worked with prominent companies in the pharmaceutical industry. He has been associated with Schering Aktiengesellschaft and Bayer Intellectual Property GmbH, where he contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing the understanding of protein kinase inhibitors.

Collaborations

Hrvatin has collaborated with esteemed colleagues, including Judi Bryant and Yuo-Ling Chou. These partnerships have fostered innovation and have been crucial in the development of his patented inventions.

Conclusion

Paul Hrvatin's contributions to the field of medicinal chemistry highlight his role as an innovator in developing therapeutic agents. His work on dihydropyridine and indolinone derivatives showcases the potential for new treatments in combating serious diseases.